Academic Journal
View in EDS

Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study

Bibliographic Details
Title: Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort study
Authors: Uprety, Dipesh a, Abrahami, Devin b, ⁎, Marcum, Zachary A. c, Li, Benjamin b, Sang, Angela b, Davis, Matthew c, Rifi, Nada b, Kelton, John M. b, Ramaswamy, Krishnan b, Sanghvi, Parag d, Bazhenova, Lyudmila d
Source: In Lung Cancer March 2025 201
Database: ScienceDirect
More Details
ISSN:01695002
DOI:10.1016/j.lungcan.2025.108436
Published in:Lung Cancer
Language:English